BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
GATA1
,
Response to oxidative stress
,
Leukemia
,
Endothelial cell
,
Biofuel
,
Quercetin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sca2 protein
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
WIF1
MXRA5
C1orf198
GLT8D2
IRX1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
DODD_NASOPHARYNGEAL_CARCINOMA_DN
SMID_BREAST_CANCER_NORMAL_LIKE_UP
MODULE_84
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
MCLACHLAN_DENTAL_CARIES_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Bursa cells cultured with Sca2+ or Sca2- stromal cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Poly(A)-binding protein is an ataxin-2 chaperone that regulates biomolecular condensates.
Stressing the role of a short linear motif in ataxin-2 condensation.
Ataxin-2, Twenty-four, and Dicer-2 are components of a noncanonical cytoplasmic polyadenylation comp…
Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2.
Toxicity of pathogenic ataxin-2 in Drosophila shows dependence on a pure CAG repeat sequence.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Integrated Functional Evaluation of the Cerebellum
Stem Cell Transplantation for Stiff Person Syndrome (SPS)
An Open Pilot Trial of BHV-4157
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ